Base exchange inhibitors of SARM1 form mononucleotide adducts and activate SARM1 in vivo
Reardon, H. T.; Guijas, C.; Clapper, J. R.; Callender, J. A.; Kozina, E. M.; Sarabia, F. J.; Hutton, C.; Herbst, D. M.; Andalis, T.; Perehinets, L.; Henry, C. L.; Lebold, T. P.; Kummer, D. A.; Blankman, J. L.; Wiener, J. J. M.; Simonsen, K. B.; Samad, T. A.
Show abstract
Activation of the NAD hydrolase SARM1 causes neuronal pathology. NAD binding to an allosteric site maintains SARM1 autoinhibition while NMN binding enables NADase activity. We evaluated SARM1 base exchange inhibitors (BEI) that exchange with nicotinamide in the SARM1 catalytic site to form inhibitor adducts. We found that BEI paradoxically activated SARM1 in some contexts, elevating both the SARM1 product cADPR and ratio to substrate, cADPR/NAD, in uninjured sciatic nerve and in healthy animals. Catalytically inactive E642A SARM1 knock-in mice were protected from elevated cADPR and cADPR/NAD in sciatic nerve after BEI dosing. Like the SARM1 activating forms of the neurotoxins Vacor and 3-acetylpyridine, BEI formed mononucleotide (MN) adducts in vivo. BEI also formed MN adducts in human THP-1 cells, as did the pyridine-containing drugs indinavir and chloroquine. These findings underscore the promiscuity of nicotinamide-related metabolism and potential for neurotoxicity arising from SARM1s susceptibility to activation by exogenous agents.
Matching journals
The top 13 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A subset of CB002 xanthine analogues bypass p53-signaling to restore a p53 transcriptome and target an S-phase cell cycle checkpoint in tumors with mutated-p53 94%
- Machine learning and biological validation identify sphingolipids as key mediators of paclitaxel-induced neuropathy in cancer patients 94%
- Cannabinoid Combination Targets NOTCH1-Mutated T-ALL Through the Integrated Stress Response Pathway 93%
Similar papers in this journal
- Unlocking the Potential: FKK6 as a Microbial Mimicry Based Therapy for Chronic Inflammation-Associated Colorectal Cancer in a Murine Model 94%
- Oral Pretreatment with Galantamine Effectively Mitigates the Acute Toxicity of a Supra-Lethal Dose of Soman in Cynomolgus Monkeys Post-treated with Conventional Antidotes 92%
- Striatal spinophilin enhances D2R interaction with cytosolic proteins to mediate persistent D2R agonist-induced locomotor suppression. 91%
Similar papers in this journal
- Small molecule nitroalkenes inhibit RAD51-mediated homologous recombination and amplify triple-negative breast cancer cell killing by DNA-directed therapies. 94%
- Unravelling the anti-cancer mechanisms elicited by non-covalent thioredoxin reductase inhibitors for triple negative breast cancer therapy. 94%
- Low level of antioxidant capacity biomarkers but not target overexpression predicts vulnerability to ROS-inducing drugs 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.